New scan could reveal if lung scarring drugs are working
NCT ID NCT05241275
Summary
This study is testing a new type of MRI scan that uses a safe, inhaled gas to see inside the lungs. The goal is to see if this scan can better track lung scarring and measure how well anti-scarring medications are working. The study will enroll 60 adults with progressive lung scarring diseases and scan them before and after starting standard medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.